Journal article icon

Journal article : Review

The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection.

Abstract:
The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in a myriad of interventions with the urgent aim of reducing the public health impact of this virus. However, a wealth of evidence both from high-income and low-income countries is accruing on the broader consequences of such interventions on economic and public health inequalities, as well as on pre-existing programmes targeting endemic pathogens. We provide an overview of the impact of the ongoing COVID-19 pandemic on hepatitis B virus (HBV) programmes globally, focusing on the possible consequences for prevention, diagnosis and treatment. Ongoing disruptions to infrastructure, supply chains, services and interventions for HBV are likely to contribute disproportionately to the short-term incidence of chronic hepatitis B, providing a long-term source of onward transmission to future generations that threatens progress towards the 2030 elimination goals.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1136/bmjgh-2020-004275

Authors


More by this author
Role:
Author
ORCID:
0000-0003-2611-1262
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-9318-2581


Publisher:
BMJ Publishing Group
Journal:
BMJ Global Health More from this journal
Volume:
6
Issue:
1
Article number:
e004275
Publication date:
2021-01-05
Acceptance date:
2020-12-09
DOI:
EISSN:
2059-7908
Pmid:
33402334


Language:
English
Keywords:
Subtype:
Review
Pubs id:
1156518
Local pid:
pubs:1156518
Deposit date:
2021-02-11

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP